Recruiting PHASE4 INTERVENTIONAL 2-arm NCT06523959

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial (ARTS)

Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial: An International Randomised Controlled Trial Evaluating Apixaban Versus No Anticoagulation in Patients Undergoing General Abdominal, Gynecologic and Urologic Surgery

Sponsor: Albany Medical College

Conditions Bleeding Venous Thromboembolism

Interventions Apixaban 2.5 MG

Updated 3 times since 2024 Last updated: May 22, 2025 Started: Jun 6, 2024 Primary completion: Sep 30, 2028 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Bleeding and Venous Thromboembolism and is currently actively recruiting participants. Albany Medical College leads this study, which shows 3 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

3 versions recorded

Jun 2025 — Present [monthly]

Recruiting PHASE4
Sep 2024 — Jun 2025 [monthly]

Recruiting PHASE4
Aug 2024 — Sep 2024 [monthly]

Recruiting PHASE4

First recorded

Jun 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Albany Medical College
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital
North Karelia Central Hospital
Oulu University Hospital
PaijatHame Central Hospital
Population Health Research Institute
Tabriz University of Medical Sciences
Tampere University Hospital
Turku University Hospital
University College, London
University of Helsinki

Data source: Clinical Urology and Epidemiology Working Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Helsinki, Finland